OntoPsic: Leveraging the Knowledge in the Treatment and Diagnosis of Telepsychiatry

2010 ◽  
Author(s):  
Fabricio da Costa Dias ◽  
Ryan Ribeiro de Azevedo ◽  
Cleyton Rodrigues ◽  
Eric Rommel Galvao Dantas ◽  
Guilherme Ataide Dias ◽  
...  
Keyword(s):  
Treatment And Diagnosis

Nanocomposites: - A Recent Overview

2020 ◽  
pp. 9-21
Author(s):  
Pavan C ◽  
Madhavi BLR
Keyword(s):  
Targeted Drug Delivery ◽  
Current Trend ◽  
Nanocomposite Films ◽  
Cancer Drug ◽  
Preparation Methods ◽  
Standard Material ◽  
Global Issues ◽  
Sustainable Solutions ◽  
Anti Cancer ◽  
Treatment And Diagnosis

Nanocomposites are substances that incorporate nanoparticles (0.5-5% by weight) into a matrix of standard material, which enhances the mechanical strength, toughness including thermal or electrical conductivity and other properties. Nanocomposites are versatile in terms of their applications such as anti-corrosive, healing of bones, sensors, environmental protection, packaging, wastewater treatment, and diagnosis of tumors and other diverse uses. They may be fabricated by blending nanofillers with a polymer to produce a composite. The current trend of processing is by polymerizing monomers. Nanocomposites serve as sustainable solutions to curb global issues. Evaluation is performed on properties such as mechanical, thermal, dispersion, and toxicological. Some marketed products of nanocomposites include In Mat (coating), FiltekZ350 XT by 3M (tooth fillers), chitosan/organic rectorite nanocomposite films (bactericidal activity), graphene oxide/Carboxymethylcellulose (targeted drug delivery of anti-cancer drug doxorubicin), MD1 Flex, Nano Clean MD1, Plactive TM (Antimicrobial nanocomposites) and NovaProTM(Tooth fillers). This article discusses about Nanocomposites–their types, preparation methods, recent research and applications.

Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure

2015 ◽  
Vol 16 (14) ◽  
pp. 1682-1697 ◽  
Author(s):  
Mónica P. A. Ferreira ◽  
Vimalkumar Balasubramanian ◽  
Jouni Hirvonen ◽  
Heikki Ruskoaho ◽  
Hélder A. Santos
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Treatment And Diagnosis

Brain-eating Amoebae Infection: Challenges and Opportunities in Chemotherapy

2019 ◽  
Vol 19 (12) ◽  
pp. 980-987 ◽  
Author(s):  
Mohammad Ridwane Mungroo ◽  
Ayaz Anwar ◽  
Naveed Ahmed Khan ◽  
Ruqaiyyah Siddiqui
Keyword(s):  
Mortality Rate ◽  
Free Living ◽  
Outdoor Activities ◽  
The Past ◽  
Free Living Amoeba ◽  
Challenges And Opportunities ◽  
Life Threatening ◽  
The Central Nervous System ◽  
Living Nature ◽  
Treatment And Diagnosis

Pathogenic free-living amoeba are known to cause a devastating infection of the central nervous system and are often referred to as “brain-eating amoebae”. The mortality rate of more than 90% and free-living nature of these amoebae is a cause for concern. It is distressing that the mortality rate has remained the same over the past few decades, highlighting the lack of interest by the pharmaceutical industry. With the threat of global warming and increased outdoor activities of public, there is a need for renewed interest in identifying potential anti-amoebic compounds for successful prognosis. Here, we discuss the available chemotherapeutic options and opportunities for potential strategies in the treatment and diagnosis of these life-threatening infections.

Optimization of Treatment and Diagnosis in Patients with Osteoporosis

TRAUMA ◽  
2016 ◽  
Vol 17 (2) ◽  
pp. 111
Author(s):  
O.M. Ihnatiev ◽  
O.M. Polivoda ◽  
M.I. Turchyn ◽  
A.V. Shanyhin
Keyword(s):  
Treatment And Diagnosis

scholarly journals Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19

2021 ◽  
Author(s):  
Amir Khodavirdipour ◽  
Motahareh Piri ◽  
Sarvin Jabbari ◽  
Mohammad Khalaj-kondori
Keyword(s):  
Diagnostic Tool ◽  
Human Kidney ◽  
World Health ◽  
Rapid Review ◽  
The Novel ◽  
Rapid Action ◽  
Antiparasitic Drug ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Treatment And Diagnosis

AbstractThe novel coronavirus disease 2019 (COVID-19) belongs to coronaviridae families, like sarbecovirus (SARS), and causes pyrexia, pertussis, and acute respiratory distress syndrome (ARDS) in major. Started from Wuhan, China now forced the World Health Organization (WHO) to call it a pandemic. These dreadful figures elevate the need for rapid action for a rapid diagnostic tool, an efficacious therapy, or vaccine for such widespread disease. Here we reviewed all the latest research and trials including conventional antiviral medicines that have a narrow and finite effect on COVID-19. Recently, some advances have been made by a nucleotide/nucleoside analogues (NUC) inhibitor (remdesivir), ivermectin (antiparasitic drug), and convalescent plasma, the later one has more recently been approved by the Food and Drug Administration (FDA). In addition, a clinical-grade soluble human angiotensin-converting enzyme (ACE2), named hrsACE2, was able to inhibit the infection of human blood vessel organoids, as well as the human kidney organoids, by the virus. As of now, innovative therapeutics based on the CRISPR/Cas13d might overcome the challenge of COVID-19 either as a treatment option or precise and rapid diagnostic tool due to its rapid and precise nature. In this updated comprehensive rapid review, we try to cover all recent findings in terms of genomics, diagnosis, prevention, and treatment.

Engineering micelles for the treatment and diagnosis of atherosclerosis

2021 ◽  
Vol 63 ◽  
pp. 102473
Author(s):  
Meng Cheng ◽  
Qiaoming Liu ◽  
Wan Liu ◽  
Fangying Yuan ◽  
Jianfang Feng ◽  
...  
Keyword(s):  
Treatment And Diagnosis
Sign in / Sign up

Export Citation Format

Share Document